Skip to main content

Immune Systems Rather than Antigenic Epitopes Elicit and Produce Protective Antibodies Against HIV

  • Chapter
  • First Online:
Book cover HIV/AIDS: Immunochemistry, Reductionism and Vaccine Design
  • 537 Accesses

Abstract

It is common parlance to refer to viral antigens and their epitopes as immunogens capable of producing antibodies (Abs) against the virus that harbours them. Words have an insiduous capacity to fashion our thinking and terms like immunogen and immunogenicity do suggest that epitopes are able to generate immune responses, although they only trigger in the host a series of reactions with B-cell receptors that eventually leads to the immune system (IS) producing a variety of antibodies. Although everyone in the field is well aware that antigens are different from immunogens, it seems that in many cases investigators do not use appropriate experimental tools for studying and controlling the immunogenicity of proteins rather than their antigenicity.

Vaccine, 2017, 35, 1985–1986.

Marc H V Van Regenmortel

Copyright © 2017 Elsevier

All rights reserved, used with permission

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Berzofsky JA. Intrinsic and extrinsic factors in protein antigenic structure. Science. 1985;229:932–40.

    CAS  PubMed  Google Scholar 

  • Mascola JR, Haynes BF. HIV-1 neutralizing antibodies: understanding nature’s pathways. Immunol Rev. 2013;254:225–44.

    Article  Google Scholar 

  • Pejchal R, Wilson IA. Structure-based vaccine design in HIV: blind men and the elephant? Curr Pharm Des. 2010;16:3744–53.

    Article  CAS  Google Scholar 

  • Scherer EM, Leaman DP, Zwick MB, McMichael AJ, Burton DR. Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions. Proc Natl Acad Sci U S A. 2010;107:1529–34.

    Article  CAS  Google Scholar 

  • Stamatatos L, Pancera M, McGuire AT. Germline-targeting immunogens. Immunol Rev. 2017;275:203–16.

    Article  CAS  Google Scholar 

  • Tomaras GD, Plotkin SA. Complex immune correlates of protection in HIV-1 vaccine efficacy trials. Immunol Rev. 2017;275:245–61.

    Article  CAS  Google Scholar 

  • Van Regenmortel MHV. Two meanings of reverse vaccinology and the empirical nature of vaccine science. Vaccine. 2011a;29:7875.

    Article  Google Scholar 

  • Van Regenmortel MHV. Basic research in HIV vaccinology is hampered by reductionist thinking. Front Immunol. 2012b;3:194. https://doi.org/10.3389/fimmu.2012.00194.

    Article  PubMed  PubMed Central  Google Scholar 

  • Van Regenmortel MHV. Specificity, polyspecificity, and heterospecificity of antibody-antigen recognition. J Mol Recognit. 2014a;27:627–39.

    Article  Google Scholar 

  • Van Regenmortel MHV. An outdated notion of antibody specificity is one of the major detrimental assumptions of the structure-based reverse vaccinology paradigm, which prevented it from developing an effective HIV-1 vaccine. Front Immunol. 2014b;5:593. https://doi.org/10.3389/fimmu.1014.00593.

    Article  PubMed  PubMed Central  Google Scholar 

  • Van Regenmortel MHV. Structure-based reverse vaccinology failed in the case of HIV because it disregarded accepted immunological theory. Int J Mol Sci. 2016b;17:1591–625. https://doi.org/10.3390/ijms17091591.

    Article  PubMed Central  Google Scholar 

  • Verkoczy L, Alt FW, Tian M. Human Ig knocking mice to study the development and regulation of broadly neutralizing antibodies. Immunol Rev. 2017;275:89–107.

    Article  CAS  Google Scholar 

  • Xiao X, Chen W, Feng Y, Zhu Z, Prabakaran P, Wang Y, Zhang MY, Longo NS, Dimitrov DS. Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens. Biochem Biophys Res Commun. 2009;390:404–9.

    Article  CAS  Google Scholar 

  • Yu L, Guan Y. Immunologic basis for long HCDR3s in broadly neutralizing antibodies against HIV-1. Front Immunol. 2014;5:250.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Van Regenmortel, M.H.V. (2019). Immune Systems Rather than Antigenic Epitopes Elicit and Produce Protective Antibodies Against HIV. In: HIV/AIDS: Immunochemistry, Reductionism and Vaccine Design. Springer, Cham. https://doi.org/10.1007/978-3-030-32459-9_22

Download citation

Publish with us

Policies and ethics